World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
17816
World Ranking
5973
National Ranking
172

Overview

Michel Arock is affiliated with the École Normale Supérieure Paris-Saclay in France and has contributed extensively to the fields of medicine, immunology, and microbiology. Their research spans various subfields including immunology and allergy, rheumatology, molecular biology, and physiology.

The scientist's main research topics include:

  • Mast cells and histamine
  • Food allergy and anaphylaxis research
  • Urticaria and related conditions
  • Asthma and respiratory diseases
  • Allergic rhinitis and sensitization
  • Melanin and skin pigmentation
  • Polyamine metabolism and applications

Michel Arock has contributed to numerous research publications, often collaborating with a core group of frequent co-authors such as Peter Valent, Olivier Hermine, Wolfgang R. Sperr, Karin Hartmann, and Andreas Reiter.

The scientist publishes regularly in several venues including:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Allergy and Clinical Immunology
  • Revue française d'allergologie
  • International Journal of Molecular Sciences
  • bioRxiv (Cold Spring Harbor Laboratory)

Notable recent papers associated with Michel Arock's research include:

  • "Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal," 2021, HemaSphere
  • "Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts," 2020, Theranostics
  • "Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes," 2022, Allergy
  • "Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study," 2021, Critical Care
  • "Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine," 2020, International Journal of Molecular Sciences

Best Publications

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

    Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

  • Cancer stem cell definitions and terminology: the devil is in the details

    Peter Valent;Dominique Bonnet;Ruggero De Maria;Tsvee Lapidot

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    Peter Valent;Cem Akin;Michel Arock;Knut Brockow

  • Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

    Patrice Dubreuil;Sébastien Letard;Marco Ciufolini;Laurent Gros

  • Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

    Sonia Varadaradjalou;Frédéric Féger;Nathalie Thieblemont;Nadine Ben Hamouda

  • Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

    Christine Bodemer;Christine Bodemer;Olivier Hermine;Olivier Hermine;Fabienne Palmérini;Ying Yang

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • Trends in histamine research: new functions during immune responses and hematopoiesis

    Elke Schneider;Malvyne Rolli-Derkinderen;Michel Arock;Michel Dy

  • KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis

    Michel Arock;Karl Sotlar;Cem Akin;Sigurd Broesby-Olsen

  • Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

    Peter Valent;Cem Akin;Wolfgang R. Sperr;Luis Escribano

  • Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

    Peter Valent;Cem Akin;Karin Hartmann;Ivan Alvarez-Twose

  • Diagnosis and treatment of systemic mastocytosis: state of the art.

    Peter Valent;Cem Akin;Wolfgang R. Sperr;Hans P. Horny

  • Mastocytosis: Pathology, genetics, and current options for therapy

    Peter Valent;Cem Akin;Wolfgang R Sperr;Matthias Mayerhofer

  • Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

    Peter Valent;Cem Akin;Karin Hartmann;Gunnar Nilsson

  • Inhibition of IgE-induced activation of human mast cells by IL-10.

    B. Royer;S. Varadaradjalou;P. Saas;J. J. Guillosson

  • The role of mast cells in host defense and their subversion by bacterial pathogens

    Frédéric Féger;Sonia Varadaradjalou;Zhimin Gao;Soman N. Abraham

  • Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.

    Fanny Lanternier;Annick Cohen-Akenine;Fabienne Palmerini;Frédéric Feger

  • Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms.

    Yael Zermati;Paulo De Sepulveda;Frederic Féger;Sebastion Létard

  • Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

    M P Purdue;Q Lan;T J Kemp;A Hildesheim

Frequent Co-Authors

Peter Valent
Peter Valent Medical University of Vienna
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Andreas Reiter
Andreas Reiter Heidelberg University
Karin Hartmann
Karin Hartmann University Hospital of Basel
Jason Gotlib
Jason Gotlib Stanford University
Cem Akin
Cem Akin University of Michigan–Ann Arbor
Dean D. Metcalfe
Dean D. Metcalfe National Institute of Allergy and Infectious Diseases
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Knut Brockow
Knut Brockow Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens many doors to exciting online degrees and career pathways in the growing life sciences sector. For those interested in the leadership side of healthcare, online doctoral programs healthcare administration offer advanced knowledge in medical management and policy shaping from anywhere in the world.

Students passionate about pharmaceuticals can pursue professional degrees at online pharmacy schools, leading to rewarding roles in clinical settings, research, and the drug industry. For those who want to integrate science with physical health and sports, consider an online bachelor's degree in exercise science. This flexible option develops expertise in fitness, performance, and rehabilitation.

Finally, a kinesiology degree online builds a strong foundation in human movement, opening up diverse roles in healthcare, sports, and wellness industries. These online pathways make it easier than ever to build a life sciences career while balancing other commitments.

Best Scientists Citing Michel Arock

Trending Scientists

Recently Published Articles